PMLI
ANAB icon

Penn Mutual Life Insurance’s AnaptysBio ANAB Stock Holding History

Penn Mutual Life Insurance’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$821K Buy
+12,000
New +$1.01M 0.66% 22

Other funds holding ANAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Penn Mutual Life Insurance's ANAB Position: Q2 2018 in Review

Penn Mutual Life Insurance opened a new position in AnaptysBio (ANAB) in Q2 2018: 12,000 shares worth $821K. The stake represents 0.66% of the portfolio and ranks #22 among its holdings.

124 funds tracked by Wall St. Rank hold ANAB as of Q2 2018.

  • Penn Mutual Life Insurance held 12,000 shares of AnaptysBio worth $821K as of Q2 2018.
  • AnaptysBio was a new Penn Mutual Life Insurance position in Q2 2018.
  • AnaptysBio made up 0.66% of Penn Mutual Life Insurance's portfolio in Q2 2018, its #22 holding.
  • 124 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2018.

Based on Penn Mutual Life Insurance's 13F filing for Q2 2018, filed 9 Aug 2018.